Philips’ Second Quarter Results 2016

Amsterdam, July 25, 2016

Report

Q2 2016 reportPDF 869.3 kB

Presentation

Q2 2016 presentationPDF 1.1 MB

Webcast

Q2 2016 transcriptPDF 207.5 kB

Philips reports Q2 sales of EUR 5.9 billion and comparable sales growth of 3%, a 9% improvement in Adjusted EBITA to EUR 544 million and net income of EUR 431 million

Second-quarter highlights

  • Comparable sales of the HealthTech portfolio continued to grow at 5%
  • Adjusted EBITA amounted to EUR 544 million, or 9.3% of sales, compared to 8.4% of sales in Q2 2015
  • EBITA totaled EUR 464 million, or 7.9% of sales, compared to 7.5% of sales in Q2 2015
  • Income from operations (EBIT) amounted to EUR 376 million, compared to EUR 349 million in Q2 2015
  • Net income amounted to EUR 431 million, including a EUR 144 million award from the Funai arbitration, compared to EUR 274 million in Q2 2015
  • Operating cash flow of EUR 318 million, compared to EUR 186 million in Q2 2015, and a free cash inflow of EUR 127 million, compared to an outflow of EUR 30 million in Q2 2015